ModifyHealth operates a turnkey food-as-medicine program that delivers medically tailored meals alongside dietitian support, remote patient monitoring, and digital education. The company serves patients through payor, employer, and healthcare system contracts, targeting chronic conditions such as type 2 diabetes, hypertension, kidney disease, obesity, and IBS. Its customizable meal plans include Low‑FODMAP, Mediterranean, gluten‑free, plant‑based, and low‑sodium options tailored to clinical needs. ModifyHealth emphasizes telenutrition and live coaching to help patients make sustainable dietary changes and improve outcomes. The company plans to accelerate growth, implement technology advancements, and enhance operations to broaden access and scale its solutions. No revenue or user metrics were disclosed in the article. ModifyHealth operates a nationwide food as medicine platform and provides medically tailored meals, working directly with patients and partnering with payors, employers, and healthcare systems. The company’s programs aim to decrease costs and improve outcomes for chronic conditions such as type 2 diabetes, hypertension, kidney disease, obesity, and irritable bowel syndrome where dietary management is recommended. Led by founder and CEO GB Pratt, ModifyHealth delivers medically tailored meal programs to patients and coordinates with healthcare stakeholders. The company intends to use its recent funding to support continued growth of its food as medicine solutions and to expand its nationwide operations. No revenue or user metrics were disclosed in the article. ModifyHealth provides gut-friendly, Low-FODMAP and gluten-free home-delivered meals combined with dietitian support and digital health solutions. Its offerings deliver evidence-based treatments for GI conditions including IBS, IBD, SIBO, and celiac disease. Led by founder and CEO GB Pratt and based in Atlanta, GA, the company packages meals and clinical support as 'food as medicine' interventions. ModifyHealth closed a $2m Series A to continue scaling those solutions. The company intends to use the funds to grow its 'food as medicine' programs and further expand nationwide operations. The goal is to deliver meaningful patient outcomes through combined nutritional therapy and digital care management.

Total raised

$26M

Funding rounds

3

Latest round

Series C

Latest activity

Dec 2024